P. Anzenbacher, Jr. et al. / Tetrahedron 60 (2004) 11163–11168
11167
Electrochemical measurements were performed in DMSO
solutions containing 0.1 M recrystallized tetrabutylammo-
nium perchlorate (TBAP) as a supporting electrolyte. TBAP
was recrystallized from absolute ethanol. A BioAnalytical
Systems Epsilon controller was used to perform the
electropolymerization reaction and the electrochemistry
experiments. A platinum wire auxiliary electrode and
Ag/AgC nonaqueous reference electrode were used for all
measurements. A scan rate of 100 mV/s was typically
employed. Under these experimental conditions the ferro-
cene/ferrocenium couple was determined to be C0.124 V
versus Ag/AgC.
114.13 CH, 118.71 C, 122.59 C, 128.12 C, 133.35 CH,
138.25 C, 145.45 C. EI/MS (70 eV): 451 (100) [MC], 486
(55), 416 (50).
3.1.3. 5,8-Di(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)-
2,3-di(1H-2-pyrrolyl)quinoxaline (1). 5,8-Dibromo-2,3-
di(1H-2-pyrrolyl)quinoxaline (50 mg, 0.12 mmol) and
2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)tributylstannane11
(258 mg, 0.6 mmol) were dissolved in dry THF (100 ml),
the solution was purged with argon for 15 min, and
PdCl2(PPh3)2 (15 mg, 0.02 mmol) was added at room
temperature under argon atmosphere. The mixture was
stirred at 100 8C under argon atmosphere for 15 h, cooled,
and concentrated on the rotary evaporator. The residue was
purified by column chromatography (DCM–hexane 3:1) to
afford an orange solid (31 mg, 48% yield). Mp O260 8C. 1H
NMR (CDCl3, d) 4.28–4.41 (m, 8H, ethylene); 6.29 (ddd,
2H, JZ2.6, 3.7, 5.4 Hz); 6.57 (s, 2H, EDOT), 7.09 (ddd, 2H,
JZ1.3, 2.5, 3.7 Hz); 7.26 (ddd, 2H, JZ1.3, 2.6, 3.6 Hz);
8.41 (s, 2H, H6); 10.03 (br s, 2H, NH). 13C APT NMR
(CDCl3, d): 65.74 CH2, 65.29 CH2, 102.20, 110.21, 113.48,
113.67, 122.10, 127.49, 127.86, 129.91, 135.90, 140.57,
141.14, 142.05. EI/MS (70 eV): m/z 540 (87) [MC], 269
(100), 267 (70). Anal. Calcd (%) for C28H20N4O4S2$0.5
H2O (549.1): C, 61.19; H, 3.85; N, 10.19; O, 13.10; S,
11.67. Found: C, 61.16; H, 3.71; N, 10.04.
Anion titrations were carried out in DMSO solutions (0.1 M
tetrabutylammonium perchlorate) of the monomer by
adding the aqueous solutions of the following anions as
tetrabutylammonium salts 5.5 mM (for chloride sensing
attempts 180 mM solution was used). Data fitting was
performed using a quadratic equation for 1:1 binding model.
Spectroelectrochemical measurements were carried out in a
custom-built sealed stirred cell using indium–tin-oxide
(ITO) coated glass slide (50!7!0.9 mm3, Rs%100 U) as
a working electrode. Electrochemical quartz crystal micro-
balance (EQCM) experiments were carried out on CHI-430
electrochemical workstation equipped with time-resolved
EQCM from CH Instruments with AT-cut polished bound
100 A CrC1000A gold-coated quartz crystals.
3.1.4. 5,8-Di(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-yl)-
2,3-di(5-chloro-1H-2-pyrrolyl)quinoxaline (1C). The
title compound was synthesized from 5,8-dibromo-2,3-
di(5-chloro-1H-2-pyrrolyl)quinoxaline according to the
procedure described above for 1. The product was a red
solid (256 mg, 33% yield). Mp O260 8C. 1H NMR (CDCl3,
d) 4.28–4.41 (m, 8H, ethylene); 6.12 (dd, 2H, JZ1.0,
3.7 Hz); 6.59 (s, 2H, EDOT), 7.17 (dd, 2H, JZ1.0, 3.7 Hz);
8.36 (s, 2H, H6); 9.95 (br s, 2H, NH). 13C APT NMR
(DMSO-d6, d): 64.43 CH2, 65.42 CH2, 103.78 CH, 108.24
CH, 112.21 C, 113.30 CH, 117.51 C, 127.51 CH, 128.13 C,
128.59 C, 135.97 C, 141.05 C, 141.81 C, 142.06 C. EI/MS
(70 eV): m/z 608 (100) [MC], 610 (78), 573 (86). HRMS
(ESI) Calcd for C28H19Cl2N4O4S2 (MCHC): m/z 609.0225.
Found: m/z 609.0219.
3.1.1. 5,8-Dibromo-2,3-di(1H-2-pyrrolyl)quinoxaline (4).
3,6-Dibromo-1,2-benzenediamine (326 mg, 1.0 mmol) and
1,2-di(1H-2-pyrrolyl)ethane-1,2-dione (188 mg, 1.0 mmol)
were dissolved in glacial acetic acid (50 ml), and heated to
reflux for 24 h shielded from ambient light. The volume of
the reaction mixture was reduced to 10% in vacuum,
dissolved in chloroform–methanol (9:1, 300 ml), washed
with 1 M NaOH, brine, and dried over anhydrous Na2SO4.
The residue after evaporation was subjected to column
chromatography on silica gel using hexane–dichloro-
methane mixture (1:3, v/v). The product was obtained as
1
yellow powder (210 mg, 50% yield). Mp 229–230 8C. H
NMR (DMSO-d6, d): 6.19 (ddd, 2H, JZ2.5, 3.7, 4.7 Hz),
6.41 (ddd, 2H, JZ1.5, 2.5, 3.7 Hz), 7.09 (ddd, 2H, JZ1.5,
2.5, 4.1 Hz), 7.92 (s, 2H), 11.39 (br s, 2H). 13C APT NMR
(DMSO-d6, d): 109.38 CH, 113.08 CH, 121.96 C, 122.98
CH, 127.75 C, 132.32 CH, 137.58 C, 145.79 C. EI/MS
(70 eV): 418 (100) [MC], 336 (15), 256 (25). Anal. Calcd
(%) for C16H10Br2N2 (418.09): C, 45.96; H, 2.41; N, 13.40.
Found: C, 45.86; H, 2.41; N, 13.22.
3.1.5. Poly-5,8-di(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-
yl)2,3-di(1H-2-pyrrolyl)quinoxaline (poly-1). The title
compound was prepared potentiodynamically from
0.5 mM solution of 1 in TBAP/ACN. Monomer oxidation
potential (onset of polymerization current): EmZ0.40 V.
Polymer half-wave oxidation: E1/2,pZ0.70 V. Band gap as
determined from vis-NIR spectroelectrochemistry in the
reduced form: EgZ1.39 eV. Conductivity: sZ54 S/cm.
3.1.2. 5,8-Dibromo-2,3-di(5-chloro-1H-2-pyrrolyl)quin-
oxaline (5). 5,8-Dibromo-2,3-di(1H-2-pyrrolyl)quinoxaline
(4) (100 mg, 0.239 mmol) was dissolved in chloroform
(50 mL) and cooled down to 0 8C. SO2Cl2 (20 mL) was
added to the reaction mixture in chloroform (15 mL). After
5 h the mixture was washed with a saturated aqueous
solution of sodium hydrogencarbonate, the organic layer
was collected, dried, and evaporated in vacuum. The residue
was subjected to column chromatography on silica gel using
hexane–dichloromethane mixture (1:3, v/v) as the eluent.
The product was obtained as a yellow powder (48 mg, 41%
3.1.6. Poly-5,8-di(2,3-dihydrothieno[3,4-b][1,4]dioxin-5-
yl)2,3-di(5-chloro-1H-2-pyrrolyl)quinoxaline (poly-1C).
The title compound was prepared potentiodynamically from
0.5 mM solution of 1C in TBAP/ACN. EmZ0.48 V. E1/2,p
Z
0.72 V. EgZ1.36 eV. sZ23 S/cm.
Acknowledgements
1
yield). Mp O260 8C. H NMR (CDCl3, d): 6.14 (dd, 2H,
JZ1.0, 3.7 Hz), 7.18 (dd, 2H, JZ1.2, 3.7 Hz), 7.70 (s, 2H),
This work was financially supported by Kraft Foods, Inc.,
NSF (NER Grant#0304320, SENSOR Grant# 0330267
9.65 (br s, 2H). 13C APT NMR (DMSO-d6, d): 108.40 CH,